Douglas B. Evans

52.4k total citations · 9 hit papers
500 papers, 36.7k citations indexed

About

Douglas B. Evans is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Douglas B. Evans has authored 500 papers receiving a total of 36.7k indexed citations (citations by other indexed papers that have themselves been cited), including 309 papers in Oncology, 197 papers in Surgery and 119 papers in Cancer Research. Recurrent topics in Douglas B. Evans's work include Pancreatic and Hepatic Oncology Research (264 papers), Neuroendocrine Tumor Research Advances (98 papers) and Cancer Genomics and Diagnostics (77 papers). Douglas B. Evans is often cited by papers focused on Pancreatic and Hepatic Oncology Research (264 papers), Neuroendocrine Tumor Research Advances (98 papers) and Cancer Genomics and Diagnostics (77 papers). Douglas B. Evans collaborates with scholars based in United States, Canada and Switzerland. Douglas B. Evans's co-authors include James L. Abbruzzese, Jeffrey E. Lee, Peter W. T. Pisters, Robert A. Wolff, Jason B. Fleming, Jean‐Nicolas Vauthey, Eddie K. Abdalla, Christopher H. Crane, Karen R. Cleary and James C. Yao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Douglas B. Evans

489 papers receiving 35.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2008 3.3k citations Manal M. Hassan, Jason B. Fleming et al. profile →
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

2015 1.4k citations Douglas B. Evans et al. profile →
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression

2008 897 citations Douglas B. Evans et al. Cancer Research profile →
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

2009 853 citations Douglas B. Evans et al. profile →
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

2006 634 citations James L. Abbruzzese, Peter W. T. Pisters et al. profile →
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

2008 592 citations Peter W. T. Pisters, Douglas B. Evans et al. profile →
Preoperative Chemoradiation and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreas

1992 571 citations Douglas B. Evans profile →
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

1999 564 citations Weixin Wang, James L. Abbruzzese et al. PubMed profile →
Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

2008 533 citations Douglas B. Evans, Peter W. T. Pisters et al. profile →

Peers

Countries citing papers authored by Douglas B. Evans

Since Specialization

Citations

This map shows the geographic impact of Douglas B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Evans more than expected).

Fields of papers citing papers by Douglas B. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Evans. The network helps show where Douglas B. Evans may publish in the future.

Co-authorship network of co-authors of Douglas B. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Evans. A scholar is included among the top collaborators of Douglas B. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Evans. Douglas B. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Surgeon compensation in academic medicine 2024 ·Surgery ·Douglas B. Evans, (unknown)	7
2	Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy 2024 ·Surgery ·(unknown), (unknown), Parag Tolat, Naveen Kulkarni, Mohammed Aldakkak, (unknown), Callisia N. Clarke, Susan Tsai, Douglas B. Evans, Kathleen K. Christians	1
3	Persistent elevation of parathyroid hormone after curative parathyroidectomy: A risk factor for recurrent hyperparathyroidism 2024 ·World Journal of Surgery ·Sophie Dream, (unknown), Kara Doffek, Tina Yen, Ty B Carroll, Joseph Shaker, Douglas B. Evans, Tracy Wang	1
4	109 Inter- and Intra-Laboratory Comparison of 6 Dustiness Testing Methods: Towards the Development of an OECD Testing Guideline 2023 ·Annals of Work Exposures and Health ·(unknown), Ana Sofia Fonseca, (unknown), Alexis Vignes, (unknown), Neeraj Shandilya, Douglas B. Evans, Thomas A. J. Kuhlbusch, Jacques Bouillard, Keld Alstrup Jensen	1
5	Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity 2023 ·Journal of Surgical Oncology ·(unknown), Mohammed Aldakkak, Kathleen K. Christians, Callisia N. Clarke, Ben George, Mandana Kamgar, Bradley A. Erickson, William A. Hall, (unknown), Naveen M. Kulkarni, (unknown), Douglas B. Evans, Susan Tsai	2
6	Wide Variability in Catecholamine Levels From Adrenal Venous Sampling in Primary Aldosteronism 2022 ·Journal of Surgical Research ·(unknown), Sophie Dream, James W. Findling, William S. Rilling, Srividya Kidambi, Steven B. Magill, Douglas B. Evans, Tracy Wang	4
7	Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism 2021 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Sophie Dream, James W. Findling, Ty B Carroll, Douglas B. Evans, Tracy Wang	25
8	DGKζ exerts greater control than DGKα over CD8 ⁺ T cell activity and tumor inhibition 2021 ·OncoImmunology ·Junchen Gu, Cindy Wang, Carolyn Cao, Jinwen Huang, Sandra Holzhauer, Heshani Desilva, (unknown), Douglas B. Evans, Joseph L. Benci, Michael Wichroski, Susan Wee, Matthew J. Riese	10
9	An Institutional experience with primary hyperparathyroidism in the elderly over two decades 2021 ·The American Journal of Surgery ·(unknown), Tina Yen, Kara Doffek, Sophie Dream, (unknown), Douglas B. Evans, Tracy Wang	9
10	The Clinical Utility of Preoperative Thyroglobulin for Surgical Decision Making in Thyroid Disease 2021 ·Journal of Surgical Research ·(unknown), Tracy Wang, Tina Yen, Kara Doffek, Douglas B. Evans, Sophie Dream	3
11	Screening guidelines and recommendations for patients at high risk of developing endocrine cancers 2020 ·Journal of Surgical Oncology ·Jennifer L. Geurts, (unknown), Tracy Wang, Douglas B. Evans, Callisia N. Clarke	6
12	Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA 2020 ·Clinical Cancer Research ·Chong Gao, (unknown), Ying Liu, Ben Staal, Ian Beddows, Dennis Plenker, Mohammed Aldakkak, (unknown), (unknown), (unknown), Peter J. Allen, Richard R. Drake, Amer H. Zureikat, Ying Huang, Douglas B. Evans, Aatur D. Singhi, Randall E. Brand, David A. Tuveson, Susan Tsai, Brian B. Haab	17
13	Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling 2015 ·Cancer Research ·Ishan Roy, Donna McAllister, (unknown), (unknown), (unknown), Noah P. Zimmerman, Anthony E. Getschman, Susan Tsai, Dannielle D. Engle, Douglas B. Evans, Brian F. Volkman, Balaraman Kalyanaraman, Michael B. Dwinell	52
14	TrkBT1 Induces Liver Metastasis of Pancreatic Cancer Cells by Sequestering Rho GDP Dissociation Inhibitor and Promoting RhoA Activation 2009 ·Cancer Research ·Zhongkui Li, Zhe Chang, (unknown), Ya’an Kang, Qianghua Xia, Cihui Zhu, Jason B. Fleming, Douglas B. Evans, Paul J. Chiao	45
15	Potential Role of Jun Activation Domain–Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma 2006 ·Cancer Research ·Maria A. Kouvaraki, Anita L. Korapati, George Z. Rassidakis, Ling Tian, Qingxiu Zhang, Paul J. Chiao, Linus Ho, Douglas B. Evans, François X. Claret	55
16	Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met– and Insulin-like Growth Factor-I Receptor–Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice 2005 ·Cancer Research ·Todd W. Bauer, Wenbiao Liu, Fan Fan, E. Ramsay Camp, Anthony Yang, Ray Somcio, Corazon D. Bucana, Jennifer Callahan, Graham C. Parry, Douglas B. Evans, Douglas D. Boyd, Andrew P. Mazar, Lee M. Ellis	120
17	Background and H2O2-induced micronuclei in peripheral blood lymphocytes as a risk factor for pancreatic cancer 2004 ·Cancer Research ·Ping Chang, Manal M. Hassan, James L. Abbruzzese, Douglas B. Evans, Robert A. Wolff, Renato Lenzi, Peter W. T. Pisters, Ajay K. Nooka, Donghui Li	3
18	NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity 2004 ·Molecular and Cellular Biology ·Shuichi Fujioka, Jiangong Niu, Christian Schmidt, Guido M. Sclabas, Bailu Peng, Tadashi Uwagawa, Zhongkui Li, Douglas B. Evans, James L. Abbruzzese, Paul J. Chiao	370
19	Palliation of malignant gastric outlet and duodenal obstruction using expandable metallic stents 1998 ·Gastrointestinal Endoscopy ·Isaac Raijman, Iqbal Siddique, Jaffer A. Ajani, Douglas B. Evans, J. L. Abbruzzese, Sandeep Lahoti, Patrick M. Lynch	2
20	Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. 1997 ·PubMed ·Ana M. Grau, Ling Zhang, Weixin Wang, Sanbao Ruan, Douglas B. Evans, James L. Abbruzzese, Wei Zhang, Paul J. Chiao	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact